Wearable devices and a digital platform to support recovery after lung cancer surgery
Tests a wearable-based digital rehabilitation system in adults having surgery for non-small cell lung cancer.
Plain-language title generated from the registry record
Registry title: The Construction and Clinical Application of an Integrated Perioperative Management System for Lung Cancer Based on Wearable Devices and Intelligent Platforms
Key facts
- Where
- Chengdu, ChinaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with non-small cell lung cancer who will have planned keyhole lung surgery. It tests a wearable-device and digital rehabilitation system around the operation.
- Age
- 18 to 85 years
- Sex
- All sexes can join.
- Disease stage
- Confirmed primary non-small cell lung cancer (NSCLC), planned for thoracoscopic lobectomy or segmentectomy meant to remove all of the disease.
Main reasons for not taking part
- Long-term home oxygen therapy before surgery, or severe respiratory failure at rest
- Severe or uncontrolled heart or lung disease, brain blood vessel disease, liver failure or kidney failure
- Other severe illness that greatly limits physical activity or rehabilitation
- Known or suspected allergy to wearable device materials or medical adhesives
- Any other condition that the investigators judge makes joining unsafe or unworkable
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
Source: NCT07310056, who can take part
Where in China
- West China HospitalChengdu, ChinaContact: Cyan DrTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- West China Hospital
- Trial code
- NCT07310056
- Record updated
- 9 September 2026
- Original description
This study aims to develop and evaluate an integrated perioperative management system based on wearable devices and a digital rehabilitation platform for patients with non-small cell lung cancer (NSCLC) undergoing thoracic surgery. By combining preoperative functional assessment using the six-minute walk test (6MWT), continuous perioperative physiological monitoring, and structured postoperative home-based digital rehabilitation, this randomized controlled trial will investigate whether the wearable-based digital management model improves short-term postoperative pulmonary function, functional recovery, and clinical outcomes compared with standard perioperative care.Read full original descriptionShow less
The Construction and Clinical Application of an Integrated Perioperative Management System for Lung Cancer Based on Wearable Devices and Intelligent Platforms
This study aims to develop and evaluate an integrated perioperative management system based on wearable devices and a digital rehabilitation platform for patients with non-small cell lung cancer (NSCLC) undergoing thoracic surgery. By combining preoperative functional assessment using the six-minute walk test (6MWT), continuous perioperative physiological monitoring, and structured postoperative home-based digital rehabilitation, this randomized controlled trial will investigate whether the wearable-based digital management model improves short-term postoperative pulmonary function, functional recovery, and clinical outcomes compared with standard perioperative care.
Inclusion: Age ≥18 years and ≤85 years; Pathologically confirmed primary non-small cell lung cancer (NSCLC); Scheduled to undergo elective curative-intent thoracoscopic lobectomy or segmentectomy; Able to independently operate a smartphone and wearable device, or able to do so with caregiver assistance; Willing to comply with study procedures and follow-up requirements; Provided written informed consent prior to participation.
Exclusion: Preoperative long-term home oxygen therapy or severe resting respiratory failure; Presence of severe or uncontrolled cardiopulmonary disease, cerebrovascular disease, hepatic insufficiency, or renal insufficiency; Severe comorbid conditions that significantly limit physical activity or adherence to rehabilitation; Known or suspected allergy to materials used in wearable devices or medical adhesives; Any other condition that, in the judgment of the investigators, makes the participant unsuitable for study participation.